J.M. Arbour’s Medtronic MDT Stock Holding History

J.M. Arbour’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263K	Buy	3,040 +776	+34%	+$74.3K	0.25%	98
2025 Q4	$217K	Buy	+2,264	New	+$220K	0.22%	108

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

J.M. Arbour's MDT Position: Q1 2026 in Review

J.M. Arbour increased its Medtronic (MDT) stake by 34% in Q1 2026, buying an estimated $74.3K and bringing the position to 3,040 shares worth $263K. The position accounts for 0.25% of the portfolio, ranked #98.

J.M. Arbour first reported a position in MDT in Q4 2025 and has held it in 2 quarters since. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

J.M. Arbour held 3,040 shares of Medtronic worth $263K as of Q1 2026.
J.M. Arbour bought 776 Medtronic shares in Q1 2026, an estimated $74.3K.
Medtronic made up 0.25% of J.M. Arbour's portfolio in Q1 2026, its #98 holding.
J.M. Arbour first reported a position in Medtronic in Q4 2025 and has held it in 2 quarters since.
2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on J.M. Arbour's 13F filing for Q1 2026, filed 21 Apr 2026.